Last updated: May 10, 2024
Sponsor: Chang Gung Memorial Hospital
Overall Status: Completed
Phase
N/A
Condition
Breast Cancer
Lymphedema
Cancer
Treatment
OPERA
Clinical Study ID
NCT06415526
202400581B0
Ages 20-80 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with ASA (American Society of Anesthesiologist) classification 1-2
Breast skin should be free from cancer involvement, with adequate tumor to skindistance, and the largest preoperative tumor size no more than 5 cm
The lesion should be located in any of the 4 quadrants away from the nipple, atleast 1 cm distance between the lesion and the nipple
Exclusion
Exclusion Criteria:
- Patients with previous pelvis surgeries (except C-section)
Study Design
Total Participants: 14
Treatment Group(s): 1
Primary Treatment: OPERA
Phase:
Study Start date:
May 03, 2024
Estimated Completion Date:
May 10, 2024
Connect with a study center
Chang Gung Memorial Hospital
Taoyuan, 33305
TaiwanSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.